ESRX

Investor Alert: Know Before You Buy These 48 Blue Chips

Greetings from the Las Vegas Money Show! before I head off to my next seminar let me update you on our status for 48 blue chip stocks More

The markets are in the middle of a strong rally, and a resurgent Apple is helping to lead the way. I still think it's a stock to sell. More

Rite Aid's turnaround continues to gain traction, but does that make it a solid investment? Decide by looking at RAD's pros and cons. More

Vivus's new new anti-obesity medication Qsymia has been added to Express Scripts coverage, cutting the price for patients by up to two-thirds. More

CVS and Walgreen reported vastly different quarters today. Is it a sign of where there's money to be made in the future? More

Hewlett-Packard and Boeing helped lead the Dow to strong gains Tuesday, while the other major indices mostly followed suit. More

Express Scripts shares plunged in Tuesday trading after the company said that earlier profit forecasts for next year were "overly aggressive." More